Literature DB >> 4621792

Use of pyocin 78-C2 in the treatment of Pseudomonas aeruginosa infection in mice.

D J Merrikin, C S Terry.   

Abstract

Purified pyocin, administered parenterally to mice infected with sensitive strains of Pseudomonas aeruginosa, afforded significant protection against two of the three strains studied.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4621792      PMCID： PMC380297          DOI： 10.1128/am.23.1.164-165.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN： 0003-6919


  2 in total

1.  On the biosynthesis of pyocyanine.

Authors:  L H FRANK; R D DEMOSS
Journal:  J Bacteriol       Date:  1959-06       Impact factor: 3.490

2.  In vitro and in vivo characterization of pyocin.

Authors:  T B Higerd; C A Baechler; R S Berk
Journal:  J Bacteriol       Date:  1967-06       Impact factor: 3.490
  2 in total
  13 in total

Review 1.  Colicinogeny and related phenomena.

Authors:  K G Hardy
Journal:  Bacteriol Rev       Date:  1975-12

2.  An Escherichia coli O157-specific engineered pyocin prevents and ameliorates infection by E. coli O157:H7 in an animal model of diarrheal disease.

Authors:  Jennifer M Ritchie; Jennifer L Greenwich; Brigid M Davis; Roderick T Bronson; Dana Gebhart; Steven R Williams; David Martin; Dean Scholl; Matthew K Waldor
Journal:  Antimicrob Agents Chemother       Date:  2011-09-26       Impact factor: 5.191

3.  Antimicrobial Weapons of Pseudomonas aeruginosa.

Authors:  Laura M Nolan; Luke P Allsopp
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Retargeting R-type pyocins to generate novel bactericidal protein complexes.

Authors:  Steven R Williams; Dana Gebhart; David W Martin; Dean Scholl
Journal:  Appl Environ Microbiol       Date:  2008-04-25       Impact factor: 4.792

5.  Antibacterial efficacy of R-type pyocins towards Pseudomonas aeruginosa in a murine peritonitis model.

Authors:  Dean Scholl; David W Martin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-10       Impact factor: 5.191

6.  Novel high-molecular-weight, R-type bacteriocins of Clostridium difficile.

Authors:  Dana Gebhart; Steven R Williams; Kimberly A Bishop-Lilly; Gregory R Govoni; Kristin M Willner; Amy Butani; Shanmuga Sozhamannan; David Martin; Louis-Charles Fortier; Dean Scholl
Journal:  J Bacteriol       Date:  2012-09-14       Impact factor: 3.490

7.  An engineered R-type pyocin is a highly specific and sensitive bactericidal agent for the food-borne pathogen Escherichia coli O157:H7.

Authors:  Dean Scholl; Mike Cooley; Steve R Williams; Dana Gebhart; David Martin; Anna Bates; Robert Mandrell
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

8.  Characterization and extrachromosomal control of bacteriocin production in Staphylococcus aureus.

Authors:  A M Jetten; G D Vogels
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

9.  Genome sequence of E. coli O104:H4 leads to rapid development of a targeted antimicrobial agent against this emerging pathogen.

Authors:  Dean Scholl; Dana Gebhart; Steven R Williams; Anna Bates; Robert Mandrell
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  A Broad-Host-Range Tailocin from Burkholderia cenocepacia.

Authors:  Guichun W Yao; Iris Duarte; Tram T Le; Lisa Carmody; John J LiPuma; Ry Young; Carlos F Gonzalez
Journal:  Appl Environ Microbiol       Date:  2017-05-01       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.